vildagliptin/metformin +pharma 50 mg/1000 mg filmtabletten
+pharma arzneimittel gmbh - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin +pharma 50 mg/850 mg filmtabletten
+pharma arzneimittel gmbh - metformin hydrochlorid; vildagliptin -
candesartan/amlodipin/hct +pharma 16 mg/10 mg/12,5 mg hartkapseln
+pharma arzneimittel gmbh - amlodipin besilat; candesartan cilexetil; hydrochlorothiazid -
candesartan/amlodipin/hct +pharma 16 mg/5 mg/12,5 mg hartkapseln
+pharma arzneimittel gmbh - amlodipin besilat; candesartan cilexetil; hydrochlorothiazid -
levofloxacin 1a pharma 250 mg - filmtabletten
1a pharma gmbh - levofloxacin hemihydrat - levofloxacin
levofloxacin 1a pharma 500 mg - filmtabletten
1a pharma gmbh - levofloxacin hemihydrat - levofloxacin
heparin gilvasan pharma 5000 i.e./ml - injektions-/infusionslösung
gilvasan pharma gmbh - heparin natrium -
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmika - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
irbesartan-1 a pharma 300 mg filmtabletten
1 a pharma gmbh (8013083) - irbesartan - filmtablette - teil 1 - filmtablette; irbesartan (27633) 300 milligramm
irbesartan-1 a pharma 150 mg filmtabletten
1 a pharma gmbh (8013083) - irbesartan - filmtablette - teil 1 - filmtablette; irbesartan (27633) 150 milligramm